This finding is in line with the previous reports of elevated chitotriosidase levels in patients with a severe hepatic phenotype of GSD IV and highlights the need for including GSD IV in the differential diagnosis of hepatosplenomegaly with elevated chitotriosidase levels. This evidence concerns the gene CHIT1 and Hepatosplenomegaly.